ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP 13D and 13G filings for BiomX Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-23 5:08 pm Sale |
2025-06-18 | 13D | BiomX Inc. PHGE |
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 276,150 1.000% |
-1,511,615 (-84.55%) |
Filing |
| 2024-07-17 8:40 pm Purchase |
2024-07-15 | 13D | BiomX Inc. PHGE |
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 1,787,765 9.990% |
529,983 (+42.14%) |
Filing |
| 2024-03-19 9:11 pm Purchase |
2024-03-15 | 13D | BiomX Inc. PHGE |
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 1,257,782 19.900% |
797,601 (+173.32%) |
Filing |
| 2024-03-08 4:30 pm Purchase |
2024-03-06 | 13D | BiomX Inc. PHGE |
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 460,181 9.900% |
4,832 (+1.06%) |
Filing |
| 2023-05-08 4:43 pm Purchase |
2023-05-04 | 13D | BiomX Inc. PHGE |
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 455,349 9.900% |
101,700 (+28.76%) |
Filing |
| 2023-03-17 4:19 pm Purchase |
2023-02-27 | 13D | BiomX Inc. PHGE |
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 353,649 10.500% |
124,600 (+54.40%) |
Filing |